KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Other Accumulated Expenses: 2010-2017

Historic Other Accumulated Expenses for Idexx Laboratories (IDXX) over the last 8 years, with Dec 2017 value amounting to $64.4 million.

  • Idexx Laboratories' Other Accumulated Expenses rose 18.53% to $65.8 million in Q1 2018 from the same period last year, while for Mar 2018 it was $65.8 million, marking a year-over-year increase of 18.53%. This contributed to the annual value of $64.4 million for FY2017, which is 10.49% down from last year.
  • According to the latest figures from FY2017, Idexx Laboratories' Other Accumulated Expenses is $64.4 million, which was down 10.49% from $72.0 million recorded in FY2016.
  • Idexx Laboratories' 5-year Other Accumulated Expenses high stood at $72.0 million for FY2016, and its period low was $44.3 million during FY2013.
  • For the 3-year period, Idexx Laboratories' Other Accumulated Expenses averaged around $67.4 million, with its median value being $65.7 million (2015).
  • In the last 5 years, Idexx Laboratories' Other Accumulated Expenses rose by 25.71% in 2014 and then fell by 10.49% in 2017.
  • Yearly analysis of 5 years shows Idexx Laboratories' Other Accumulated Expenses stood at $44.3 million in 2013, then climbed by 25.71% to $55.7 million in 2014, then climbed by 17.99% to $65.7 million in 2015, then grew by 9.62% to $72.0 million in 2016, then declined by 10.49% to $64.4 million in 2017.